Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

Merck
CN
All Photos(1)

Key Documents

G006151

UHPLC/MS Analysis of Antineoplastic and Antidepressant Drugs in Plasma on Titan C18 after SPE using HybridSPE®-PLus

application for HPLC, application for SPE

Sign Into View Organizational & Contract Pricing

Select a Size

500 G
¥749.51
1 KG
¥1,285.94

¥749.51

List Price¥1,199.21Save 37%

Available to ship on2025年4月25日Details



Select a Size

Change View
500 G
¥749.51
1 KG
¥1,285.94

About This Item


¥749.51

List Price¥1,199.21Save 37%

Available to ship on2025年4月25日Details


technique(s)

HPLC: suitable
solid phase extraction (SPE): suitable

test parameters

sample/matrix: rat plasma
SPE well plate: HybridSPE-PLus 96-Well Plate, 50 mg/2 mL per well (575659-U)
sample preparation: final analyte concentration 50 ng/mL
sample addition: 400 μL of 1% formic acid acetonitile:spiked plasma (3:1) per well
column: Titan C18, 5 cm x 2.1 mm I.D., 1.9 μm particles (577122-U)
mobile phase: [A] 5 mM ammonium formate; [B] 5 mM ammonium formate in 90:10 (v:v) acetonitrile:water
gradient: 35 to 90% B in 1.5 min, held at 90% B for 0.4 min
flow rate: 0.4 mL/min
pressure: 3582 psi (247 bar)
column temp.: 35 °C
detector: TOF/MS
injection: 1 μL

suitability

application for HPLC
application for SPE

application(s)

pharmaceutical (small molecule)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
A614111213V800035
vapor density

2.7 (vs air)

vapor density

2.7 (vs air)

vapor density

2.7 (vs air)

vapor density

2.7 (vs air)

product line

BioUltra

product line

ReagentPlus®

product line

-

product line

Vetec

assay

≥99.5% (T)

assay

≥99.0%

assay

99-101%

assay

≥98.5%

form

powder or crystals

form

powder or crystals

form

powder or crystals

form

crystalline powder

impurities

insoluble matter, passes filter test

impurities

-

impurities

residual solvents, complies, tar like substances, complies, ≤0.001% heavy metals (as Pb), ≤0.01% non-volatile matter

impurities

-

pH

7.0-8.5 (25 °C, 1 M in H2O)

pH

7-8.5 (25 °C, 79.1 g/L)

pH

7-8.5 (25 °C, 79.1 g/L)

pH

7.0-8.5 (25 °C, 79.1 g/L)

Analysis Note

HybridSPE-Phospholipid plates removed plasma-derived proteins and phospholipids to maximize LC/MS sensitivity. Titan C18 U/HPLC columns provided rapid resolution. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

Legal Information

HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyte

Description

    Fluoxetine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
    Tamoxifen, ≥99%

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service